Tuesday, June 16, 2026

IU Opens Up About Skeeter Syndrome: Severe Allergic Reactions to Mosquito Bites

IU reveals her struggle with Skeeter Syndrome, a severe allergic reaction to mosquito bites, causing painful swelling and skin issues.

A DICTATOR’S DIET: Kim Jong Un Cuts Food Supply To Fund His Personal Anti-Aging Hospital

North Korea imported $2.1M in medical equipment from China for a new hospital, while crop imports decreased in October.

Suspicious North Korean Tankers Detected

On May 23, Voice of America (VOA)...

Tag: CAR-T therapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.